Skip to main content
. 2020 Nov 6;8(21):5172–5179. doi: 10.12998/wjcc.v8.i21.5172

Table 2.

Comparison of efficacy between the two groups, n %

Curative effect
S-1 group (n = 47)
Gemcitabine group (n = 47)
χ 2 /t
P value
Complete remission 3 (6.38) 2 (4.26) 0.446 0.504
Remission 13 (27.66) 12 (25.53) 0.116 0.733
Controlled 17 (36.17) 18 (38.30) 0.097 0.755
Progressed 14 (29.79) 15 (31.91) 0.105 0.746
Total effective rate of treatment 16 (34.04) 14 (29.79) 0.416 0.519